1. India Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
Gian Life Care Ltd.

Gian Life Care Ltd.

BBSE:GIANLIFE
4.26
INR
+0.11
(+2.65%)
-0.92EPS
86.66MMarket Cap
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
9.65
10.11
15.42
11.53
12.69
6.41
3.61
Basic EPS, GAAP
- -
1.42
1.95
4.23
1.03
4.02
-0.04
-0.92
Free Cash Flow per Basic Share
- -
1.67
2.35
0.35
0.57
-0.28
0.25
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.08
7.39
9.34
13.56
14.62
18.63
18.58
- -
Tangible Book Value per Share
0.04
7.36
9.32
13.54
14.61
18.62
18.58
- -
Basic Weighted Avg Shares
10
8
10
10
10
10
10
10
Sales/Revenue/Turnover
- -
76
105
159
119
131
66
38
Operating Margin (%)
- -
23.85
27.03
35.75
11.33
43.15
6.86
-12.44
Depreciation Expense
- -
3
3
3
5
5
6
6
Net Income, GAAP
- -
11
20
44
11
42
- -
-10
Effective Tax Rate (%)
- -
27.66
26.78
25.28
33.23
27.75
196.88
- -
Profit Margin (%)
- -
14.74
19.29
27.44
8.92
31.65
-0.56
-25.34
Working Capital
-33
3
10
35
7
31
57
- -
LT Debt
10
8
6
19
16
23
31
- -
Total Equity
1
76
97
140
151
193
192
- -
Return on Invested Capital (%)
- -
21.46
20.28
28.46
4.27
14.75
-0.98
- -
Return on Capital (%)
- -
22.41
23.08
31.73
7.05
20.48
-2.17
- -
Return on Common Equity (%)
- -
29.2
23.33
36.91
7.3
24.16
-0.19
- -

Capital Structure

INR

•

in mil. unless spec.
Jun'26
Sep'26
Dec'26
ST Debt
- -
29
- -
LT Borrowings
- -
28
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
10
10
10
Market Capitalization
155
161
87

Working Capital

INR

•

in mil. unless spec.
Jun'26
Sep'26
Dec'26
Total Current Assets
- -
195
- -
Cash, Cash Equivalents & STI
- -
75
- -
Accounts Receivable, Net
- -
61
- -
Inventories
- -
6
- -
Total Current Liabilities
- -
117
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
29
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
21.33%
-0.23%
Free Cash Flow
- -
-54.79%
-188.41%
Net Income, GAAP
- -
61.91%
-100.9%
Sales/Revenue/Turnover
- -
4.91%
-49.46%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
24
23
38
46
131
2025
20
19
16
11
66
2026
9
7
11
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.26
0.2
1.5
2.06
4.02
2025
0.09
0.12
0.34
-0.58
-0.04
2026
0.05
-0.5
0.1
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Arun Kumar Gupta
Full Time Employees
24
Sector
Health services
Industry
Medical/Nursing services
Address
7/216 (6), Swaroop Nagar Kanpur UP India 208002
IPO Date
Jan 13, 2020
Website
admission.nitteftid.com
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Mobile-health Network Solutions (NASDAQ:MNDR)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
Gian Life Care Limited is an India-based provider of diagnostic and related healthcare testing services. Incorporated in 2018 and headquartered in Kanpur, Uttar Pradesh, the company offers a comprehensive range of over 1,344 pathology and diagnostic tests including biochemistry, clinical pathology, coagulation, cytogenetics, cytology, hematology, histopathology, immunoassay, microbiology, molecular biology, radiology services such as digital x-ray, mammography and sonography, as well as patient diagnosis, prevention and wellness services to individual patients, hospitals, corporates and other healthcare providers primarily across Kanpur, Lucknow and nearby cities in Uttar Pradesh. The company operates NABL-accredited and ISO 9001:2015-certified facilities with subsidiaries including Gian Path Lab (India) Pvt Ltd and Gian Satguru Pathology LLP. In recent developments, its Lucknow laboratory became fully operational in fiscal year 2023 to support network expansion; the company completed an SME initial public offering in early 2020 raising approximately Rs 3.12 crore to fund new processing centers; it agreed to acquire a 60% stake in Svasthyam Healthcare Private Limited in November 2021; and in November 2024 approved an increase in authorized share capital from Rs 12 crore to Rs 42 crore alongside board approvals for financial results and statutory compliance matters.